Header Logo

Connection

ANNE TSAO to Clinical Trials, Phase II as Topic

Back to Details
This is a "connection" page, showing publications ANNE TSAO has written about Clinical Trials, Phase II as Topic.
ANNE TSAO
Connection Strength
0.020
Clinical Trials, Phase II as Topic
  1. Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcome. J Natl Cancer Inst. 2012 Feb 08; 104(3):228-39.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.